BBNX biotech catalysts & pipeline

BETA BIONICS INC · Data as of 2026-10-25

Upcoming catalysts

3D Intelligence — Regulatory decision

mid-2027

Expect to expand the algorithm's indications for use to adults with T2D in the U.S. around mid-20271

iLet — Regulatory decision

Mid 2027

Beta Bionics expects to expand iLet's indications for use to adults with type 2 diabetes in the U.S. around mid-year 2027, subject to regulatory clearance by the FDA.

Source filing

Explore the free biotech catalyst calendar